Emcure Pharmaceuticals shares hit a record high after rising 16% in two sessions, following strong Q2FY27 results. Profit increased 29% and revenue grew 24%. Jefferies and Kotak retained Buy ratings, citing growth prospects and setting target prices of ₹2,500 and ₹2,450.
Emcure Pharmaceuticals shares hit a record high after rising 16% in two sessions, following strong Q2FY27 results. Profit increased 29% and revenue grew 24%. Jefferies and Kotak retained Buy ratings, citing growth prospects and setting target prices of ₹2,500 and ₹2,450.
<iframe src="https://hindustansphere.com/embed/cluster/e19f368db960d25cb05ba31d329ab17326c13a75" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Emcure Pharma shares at record high! Stock soars 10% today, up 16% in 2 days: More rally ahead? Buy, sell or hold?"></iframe>
